InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
63,166.79
(
-0.33%
)
Post# of 316941
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cintrix

Send PM Follow Ignore
Followers 363
Posts 113991
Boards Moderated 5
Alias Born 12/28/2000

cintrix

Member Level

Re: None

Tuesday, 08/14/2018 1:48:05 PM

Tuesday, August 14, 2018 1:48:05 PM

Post# of 316941
OPTN down 29% posted better-than-expected Q2 results earlier today.
The culprit may be management's commentary on revenue and average selling price (ASP) for XHANCE (fluticasone propionate) Nasal Spray, approved by the FDA almost a year ago for the treatment of nasal polyps.
https://seekingalpha.com/news/3382579-optinose-23-percent-q2-report
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up